Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
42 pending office actions • 28 clients • 41 examiners • 25 art units • 0 of 42 (0%) have an AI response strategy ready
PORTER WRIGHT MORRIS & ARTHUR, LLP manages 1824 career applications in Biotechnology & Pharmaceuticals. The firm has a resolved allowance rate of 85.07 percent. Prosecution involves an average of 3.35 office actions per allowance. There are 32 pending office actions currently.
The 85.07 percent allowance rate is a strong indicator of success. The 3.35 office actions per allowance figure reflects the complexity of the biotechnology sector. With 1824 career applications, the firm has a substantial track record. This data indicates that the firm consistently achieves success through a persistent prosecution strategy involving multiple rounds of examiner interaction.
Based on the USPTO statutory response window for each pending office action. 11 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 11 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (2%) |
| §101 + other | 6 (14%) |
| §103 only | 11 (26%) |
| §102 only | 1 (2%) |
| §112 only | 3 (7%) |
| Double-patenting + other | 3 (7%) |
| Multi-statute (no §101) | 17 (40%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HOEKSTRA, JEFFREY GERBEN | 2 | 56.5% | +39.1% |
| CHRISTENSEN, DANIELLE M | 1 | 79.4% | +11.3% |
| DEERY, ERIN LEAH | 1 | 58.3% | +49.1% |
| SHANSKE, JASON D | 1 | 76.3% | +14.2% |
| NGUYEN, LOAN T | 1 | 64.6% | +23.7% |
| ARCORIA, PAUL JOSEPH | 1 | — | — |
| MISHRA, DEEPA | 1 | 29.3% | +35.2% |
| BERRY, LAYLA D | 1 | 66.0% | +9.0% |
| BADAWI, ANGIE M | 1 | 59.2% | +37.6% |
| TICHY, JENNIFER M.H. | 1 | 64.9% | +34.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17925238 | IMPROVEMENTS TO APPARATUS AND METHODS FOR MANIPULATING MICRODROPLETS | XU, QING | 42d overdue |
| 18246705 | PROBE-GUIDE FOR IDENTIFYING AND HARVESTING A BIOPSY | HOEKSTRA, JEFFREY GERBEN | 38d overdue |
| 17534548 | Analyte Detection Method Employing Concatemers | RAYMONDA, MATTHEW HAROLD | 2d overdue |
| 19367660 | A FAN COVER AND A METHOD OF DIVERTING OUTPUT AIR USING FAN COVER | CHRISTENSEN, DANIELLE M | — |
| 19061380 | Toilet Training Seat | DEERY, ERIN LEAH | — |
| 19056408 | TWO-PIECE THREADED FASTENER ASSEMBLY | SHANSKE, JASON D | — |
| 19053339 | SYSTEM AND METHOD FOR AUTOMATICALLY IDENTIFYING IMPORTANT NEWS ACROSS LARGE DATASETS | NGUYEN, LOAN T | — |
| 18915716 | METHODS FOR PREDICTING AUTOIMMUNITY POST GENE THERAPY | MISHRA, DEEPA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18246705 | PROBE-GUIDE FOR IDENTIFYING AND HARVESTING A BIOPSY | HOEKSTRA, JEFFREY GERBEN | 38d overdue |
| 19367660 | A FAN COVER AND A METHOD OF DIVERTING OUTPUT AIR USING FAN COVER | CHRISTENSEN, DANIELLE M | — |
| 19061380 | Toilet Training Seat | DEERY, ERIN LEAH | — |
| 19056408 | TWO-PIECE THREADED FASTENER ASSEMBLY | SHANSKE, JASON D | — |
| 19053339 | SYSTEM AND METHOD FOR AUTOMATICALLY IDENTIFYING IMPORTANT NEWS ACROSS LARGE DATASETS | NGUYEN, LOAN T | — |
| 18915716 | METHODS FOR PREDICTING AUTOIMMUNITY POST GENE THERAPY | MISHRA, DEEPA | — |
| 18841078 | NON-CONTACT OXYGEN SATURATION ESTIMATION USING AMBIENT LIGHT | HOEKSTRA, JEFFREY GERBEN | — |
| 18775990 | MULTI-REFERENCE EVENT SUMMARIZATION | BADAWI, ANGIE M | — |
| Art Unit | Apps |
|---|---|
| 1798 | 3 |
| 1797 | 3 |
| 1653 | 2 |
| 1623 | 2 |
| 1758 | 2 |
| 1684 | 2 |
| 3745 | 1 |
| 2165 | 1 |
| 1629 | 1 |
| 1638 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19367660 | A FAN COVER AND A METHOD OF DIVERTING OUTPUT AIR USING FAN COVER | VERTIV CORPORATION | CHRISTENSEN, DANIELLE M | 3745 | §102§112 | Non-Final OA | — | Pending | Oct 23, 2025 |
| 19061380 | Toilet Training Seat | Mykidzy LLC | DEERY, ERIN LEAH | §103§112 | Non-Final OA | — | Pending | Feb 24, 2025 | |
| 19056408 | TWO-PIECE THREADED FASTENER ASSEMBLY | Tite-Spot, LLC | SHANSKE, JASON D | §102§103Other | Non-Final OA | — | Pending | Feb 18, 2025 | |
| 19053339 | SYSTEM AND METHOD FOR AUTOMATICALLY IDENTIFYING IMPORTANT NEWS ACROSS LARGE DATASETS | Primer Technologies, Inc. | NGUYEN, LOAN T | 2165 | §101§103§112 | Final Rejection | — | Pending | Feb 13, 2025 |
| 18863395 | SELECTIVE DOPAMINE INCREASE | Sobrera Pharma AB | ARCORIA, PAUL JOSEPH | 1629 | §103 | Non-Final OA | — | Pending | Nov 06, 2024 |
| 18915716 | METHODS FOR PREDICTING AUTOIMMUNITY POST GENE THERAPY | Children'S Hospital Medical Center | MISHRA, DEEPA | §101§103§112 | Non-Final OA | — | Pending | Oct 15, 2024 | |
| 18841078 | NON-CONTACT OXYGEN SATURATION ESTIMATION USING AMBIENT LIGHT | Detectivio AB | HOEKSTRA, JEFFREY GERBEN | §101§102§112 | Non-Final OA | — | Pending | Aug 23, 2024 | |
| 18781181 | USE OF DEXTRAN SULFATE | Tx Medic AB | BERRY, LAYLA D | §103DP | Non-Final OA | — | Pending | Jul 23, 2024 | |
| 18775990 | MULTI-REFERENCE EVENT SUMMARIZATION | Primer Technologies, Inc. | BADAWI, ANGIE M | §101§102§103 | Non-Final OA | — | Pending | Jul 17, 2024 | |
| 18667066 | BACTERIA CLASSIFICATION AND ANALYSIS | Sysmex Corporation | TICHY, JENNIFER M.H. | 1653 | §102§112 | Non-Final OA | — | Pending | May 17, 2024 |
| 18681294 | TAMPON INSERTION DEVICE AND METHOD | Tina Holdings, LLC | WRUBLESKI, MATTHEW JAMES | §102§103DP | Non-Final OA | — | Pending | Feb 05, 2024 | |
| 18578381 | DIFFERENTIAL CXCR4 EXPRESSION ON HEMATOPOIETIC PROGENITOR CELLS VERSUS STEM CELLS DIRECTS HOMING AND LONG-TERM ENGRAFTMENT | Children'S Hospital Medical Center | AMICK, THOMAS RUSSE | 1638 | §102 | Non-Final OA | — | Pending | Jan 11, 2024 |
| 18577441 | IMPROVEMENTS IN OR RELATING TO A METHOD OR AN APPARATUS FOR DETECTING AN INTERACTION BETWEEN A BIOLOGICAL ENTITY AND A MOLECULE | Lightcast Discovery Ltd. | SODERQUIST, ARLEN | §102§103§112 | Non-Final OA | — | Pending | Jan 08, 2024 | |
| 18573570 | NEW USE OF MONENSIN | Marco Maccarana | VALLE, ERNESTO | 1623 | §102§103§112 | Non-Final OA | — | Pending | Dec 22, 2023 |
| 18572370 | PREDICTING CANCER RELAPSE | Arocell AB | FONTAINHAS, AURORA M | §101§102§103§112DP | Non-Final OA | — | Pending | Dec 20, 2023 | |
| 18556408 | ADENOVIRUS FOR TREATMENT OF CANCER | Elicera Therapeutics AB | CANDELARIA, JULIANA IRENE | 1634 | §102§103§112 | Non-Final OA | — | Pending | Oct 20, 2023 |
| 18556183 | COMPOSITIONS AND METHODS FOR CELL-FREE NUCLEIC ACID ISOLATION | Simsen Diagnostics AB | PHAM, KHAI QUYNH TIEN | 1682 | §102§103 | Non-Final OA | — | Pending | Oct 19, 2023 |
| 18282396 | METHOD OF SELECTING CELLS | Lightcast Discovery Ltd. | LUSI, ELLIS FOLLETT | 1636 | §112 | Non-Final OA | — | Pending | Sep 15, 2023 |
| 18263146 | METHOD OF PROVIDING BROAD-SPECTRUM RESISTANCE TO PLANTS, AND PLANTS THUS OBTAINED | Naga Charan Konakalla | ORDAZ, CHRISTIAN JOSE | 1663 | §112 | Final Rejection | 97d overdue | Pending | Jul 27, 2023 |
| 18252813 | REFINED USES OF GABA A RECEPTOR MODULATORS IN TREATMENT OF FRAGILE X SYNDROME | Children'S Hospital Medical Center | WHITE, DENNIS MICHAEL | 1758 | §102§103Other | Final Rejection | — | Pending | May 12, 2023 |
| 18030136 | IMPROVEMENTS IN OR RELATING TO A DEVICE AND METHODS FOR FACILITATING MANIPULATION OF MICRODROPLETS | Lightcast Discovery Ltd. | HERON, VELVET ELIZABETH | 1798 | §102§103 | Final Rejection | — | Pending | Apr 04, 2023 |
| 18030132 | IMPROVEMENTS IN OR RELATING TO A DEVICE AND METHODS FOR FACILITATING MANIPULATION OF MICRODROPLETS | Lightcast Discovery Ltd. | MUI, CHRISTINE T | 1797 | §103§112 | Final Rejection | — | Pending | Apr 04, 2023 |
| 18030130 | IMPROVEMENTS IN OR RELATING TO A DEVICE AND METHODS FOR FACILITATING MANIPULATION OF MICRODROPLETS | Lightcast Discovery Ltd. | CHIU, MAY LEUNG | 1758 | §103 | Final Rejection | 27d | Pending | Apr 04, 2023 |
| 18246705 | PROBE-GUIDE FOR IDENTIFYING AND HARVESTING A BIOPSY | Fluolink AB | HOEKSTRA, JEFFREY GERBEN | 3791 | §102§103§112 | Final Rejection | 38d overdue | Pending | Mar 27, 2023 |
| 18172388 | CARTRIDGE AND METHOD OF ANALYSING A BIOLOGICAL SAMPLE | Sysmex Corporation | KWAK, DEAN P | 1798 | §102§112Other | Non-Final OA | — | Pending | Feb 22, 2023 |
| 18109074 | SYSTEM FOR SYSTEM FOR PREPARING HIGH-PURITY TAURINE AND SALT | Qianjiang Yongan Pharmaceutical Co. Ltd. | KUYKENDALL, ALYSSA LEE | 1774 | §103 | Non-Final OA | 79d overdue | Pending | Feb 13, 2023 |
| 18040074 | CALCIUM-DEFICIENT SILICATE-SUBSTITUTED CALCIUM PHOSPHATE APATITE COMPOSITIONS AND METHODS | Ossdsign AB | LIU, TRACY | 1614 | §103 | Non-Final OA | 70d | Pending | Jan 31, 2023 |
| 18006745 | PREDICTING CANCER RELAPSE AND TREATMENT OF CANCER DISEASES | Fredrik Johansson Swartling | KOVACH, KARA NICOLE | 1681 | §103 | Final Rejection | 41d | Pending | Jan 25, 2023 |
| 18002526 | Functionalized Blood Sampling Device and Method for PEth Measurement | Capitainer AB | GZYBOWSKI, MICHAEL STANLEY | 1798 | §103 | Final Rejection | 147d overdue | Pending | Dec 20, 2022 |
| 18067211 | SENSOR UNIT, MEASURING METHOD AND PRODUCTION METHOD | Presens Precision Sensing GmbH | GERIDO, DWAN A | 1797 | §102§103§112 | Non-Final OA | — | Pending | Dec 16, 2022 |
| 18001080 | LYMPHOCYTE CLONALITY DETERMINATION | Simsen Diagnostics AB | YOUNG, BRIAN ELLIS | 1684 | §103DP | Final Rejection | 15d | Pending | Dec 08, 2022 |
| 17925238 | IMPROVEMENTS TO APPARATUS AND METHODS FOR MANIPULATING MICRODROPLETS | Lightcast Discovery Ltd. | XU, QING | 1656 | §102§103 | Final Rejection | 42d overdue | Pending | Nov 14, 2022 |
| 17958287 | SYSTEM AND METHOD TO ENGINEER USER EXPERIENCE | Cigniti Technologies Limited | MORSHED, HOSSAIN M | 2191 | §101 | Final Rejection | — | Pending | Sep 30, 2022 |
| 17907712 | Multi-Well Plates for Creation of High-Density Arrays of Compartmentalized Cell Cultures for Usage in High Capacity Applications | Cellectricon AB | GIERE, REBECCA M | 1677 | §112 | Non-Final OA | 52d overdue | Pending | Sep 29, 2022 |
| 17794286 | PREDICTING PATIENT SURVIVAL | Arocell AB | DUNN, MCKENZIE A | 1678 | §103 | Non-Final OA | — | Pending | Jul 21, 2022 |
| 17858296 | MICROFLUIDIC DEVICES | Capitainer AB | GERHARD, ALISON CLAIRE | 1797 | §103 | Non-Final OA | — | Pending | Jul 06, 2022 |
| 17785455 | PLATELET CONCENTRATE CONTROL | Cyteguard AB | CHOWDHURY, TARIFUR RASHID | 2877 | §103 | Final Rejection | — | Pending | Jun 15, 2022 |
| 17776644 | PEG-LIPID | Icoat Medical AB | BAKSHI, PANCHAM | 1623 | §103 | Non-Final OA | — | Pending | May 13, 2022 |
| 17767730 | METHOD AND APPARATUS FOR CLINICAL TESTING | Lightcast Discovery Ltd. | AFREMOVA, VERA | 1653 | §103§112 | Non-Final OA | — | Pending | Apr 08, 2022 |
| 17642510 | IN VITRO FERTILISATION (IVF) EMBRYO VIABILITY AND QUALITY ASSAY | UNIVERSITY OF TARTU | BAUSCH, SARAE L | 1699 | §101§102§112 | Final Rejection | — | Pending | Mar 11, 2022 |
| 17534548 | Analyte Detection Method Employing Concatemers | Olink Proteomics AB | RAYMONDA, MATTHEW HAROLD | 1684 | §102§103 | Non-Final OA | 2d overdue | Pending | Nov 24, 2021 |
| 17297112 | EX VIVO ORGAN TREATMENT WITH PEG-PHOSPHOLIPID MOLECULES | Icoat Medical AB | BEHARRY, ZANNA MARIA | 1632 | §103 | Final Rejection | — | Pending | May 26, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial